Skip to main content
All lobbying filings

CROSSROADS STRATEGIES, LLC

Lobbying for THE BOEING COMPANY · aerospace and aviation manufacturing

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2025 · Virginia · House · Senate · $110,000.00 income · posted Apr 21, 2025

Official filing document

 Bills named in this filing 2
  • HR 1026
    Primary Care Enhancement Act of 2025
  • HR 1968
    Full-Year Continuing Appropriations and Extensions Act, 2025
 Lobbying activity 2
Health Issues

H.R.1026, Primary Care Enhancement Act; General health care and employee benefits issues; and cost containment.

Aerospace

Issues related to aviation and aerospace programs in FAA Reauthorization Act of 2024 (P.L.118-63) implementation, H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (P.L.119-4), FY2026 National Defense Authorization Act, FY2026 Department of Defense Appropriations, FY2026 Transportation, Housing and Urban Development, and Related Agencies Appropriations, and the FY2025 Budget Reconciliation Process. Issues related to oversight of aviation safety including Congressional hearings.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem